| CHD | Chediak-Higashi disease; childhood disease; chronic hemodialysis; congenital or congestive heart dis... |
|---|---|
| AMI | acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial... |
| ASA | acetylsalicylic acid; active systemic anaphylaxis; Adams-Stokes attack; American Society of Anesthes... |
| FCI | fixed-cell immunofluorescence; food chemical intolerance |
| FI | fasciculus intrafascicularis; fever caused by infection; fibrinogen; fixed interval; flame ionizatio... |
| 8-lysine vasopressin | <chemical> 8-lysyl vasopressin. The porcine antidiuretic hormone most frequently used clinically. A cyclic nonapeptide with lysine in position 8 of the chain; it is used to treat diabetes insipidus and as haemostatic because of its vasoconstrictor action. Pharmacological action: haemostatics, renal agents, vasoconstrictor agents. Chemical name: Vasopressin, 8-L-lysine- (12 Dec 1998) |
|---|---|
| fructosyl lysine oxidase | <enzyme> Isolated from fusarium oxysporum; mw 50 kD; catalyses the h2o2-producing deglycating oxidation of n(alpha/epsilon)-fructosyl-n(alpha/epsilon) )-z-lysine Registry number: EC 1.4.3.- (26 Jun 1999) |
| L-lysine oxidase | <enzyme> Converts l-lysine to 2-oxo-6-aminohexanoate Registry number: EC 1.4.3.14 Synonym: l-lysine-alpha oxidase (26 Jun 1999) |
| lysine | <amino acid> The only carrier of a side chain primary amino group in proteins. Has important structural and chemical roles in proteins. (18 Nov 1997) |
| lysine carboxypeptidase | <enzyme> A serine carboxypeptidase that removes c-terminal amino acids, preferentially lysine, from peptides and proteins. It inactivates bradykinin by this action. Registry number: EC 3.4.17.3 (12 Dec 1998) |
| lysine-C peptidase | <enzyme> Used in amino acid sequence determinations Registry number: EC 3.4.99.- Synonym: lysine specific peptidase (26 Jun 1999) |
| lysine decarboxylase | <enzyme> Do not confuse with cada atpase Registry number: EC 4.1.1.18 Synonym: cad a gene product, cada lysine decarboxylase (26 Jun 1999) |
| lysine epsilon-dehydrogenase | <enzyme> From agrobacterium tumefaciens; forms alpha-aminoadipate delta-saemialdehyde which is spontaneously converted to delta 1-piperideine-6-carboxylate Registry number: EC 1.4.1.- Synonym: l-lysine epsilon-dehydrogenase (26 Jun 1999) |
| lysine monooxygenase | <enzyme> Minor descriptor (75-82); online and index medicus search oxygenases (75-82) Registry number: EC 1.13.12.2 Synonym: lysine oxygenase (26 Jun 1999) |
| lysine N-epsilon hydroxylase | <enzyme> Do not confuse with lysine hydroxylase, which forms 5-hydroxylysine Registry number: EC 1.14.13.- Synonym: n-epsilon lysine monooxygenase, iucd protein, aera protein, lysine n(6)-hydroxylase (26 Jun 1999) |
| lysine-p-nitroanilide hydrolase | <enzyme> Hydrolyses a wide variety of di-, tri-, and tetrapeptides, and polypeptides up to 15 amino acids; it is blocked only if proline is in the penultimate position from n-terminus or if n-terminus is blocked, e.g. Pyroglutamyl residue Registry number: EC 3.4.- Synonym: lysine-4-nitroanilide hydrolase, lys-pna hydrolase (26 Jun 1999) |
| lysine racemase | <enzyme> Interconverts the d- and l-isomers Registry number: EC 5.1.1.5 (26 Jun 1999) |
| lysine-trna ligase | <enzyme> An enzyme that activates lysine with its specific transfer RNA. Chemical name: L-Lysine:tRNA(Lys) ligase (AMP-forming) Registry number: EC 6.1.1.6 (12 Dec 1998) |
| adrenal hyperplasia, congenital | A group of inherited disorders of adrenal steroidogenesis, the physical expression of which varies with the sex of the patient, the severity of the congenital enzyme defect, and the age at which the defect makes its presence felt. The most common form, the simple virilizing form, is due to a 21-hydroxylase deficiency. There is also a salt-losing form (a more complete 21-hydroxylase deficiency), a hypertensive form (11-hydroxylase deficiency), a 17-hydroxylase deficiency form, a desmolase deficiency form, and a 3-beta-hydroxysteroid deficiency form. (12 Dec 1998) |
| anaemia, dyserythropoietic, congenital | A familial disorder characterised by anaemia with multinuclear erythroblasts, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors. Type II is the most common of the 3 types of congenital dyserythropoietic anaemia; it is often referred to as hempas, based on the hereditary erythroblast multinuclearity with positive acidified serum test. (12 Dec 1998) |